Secondary |
Mycobacterium Avium Complex Infection |
18.3% |
Short-bowel Syndrome |
16.9% |
Hypertension |
8.5% |
Crohn's Disease |
5.6% |
Drug Use For Unknown Indication |
5.6% |
Product Used For Unknown Indication |
5.6% |
Angina Pectoris |
2.8% |
Antiphospholipid Syndrome |
2.8% |
Arrhythmia |
2.8% |
Benign Prostatic Hyperplasia |
2.8% |
Depression |
2.8% |
Diabetes Mellitus |
2.8% |
Dyspepsia |
2.8% |
Hypothyroidism |
2.8% |
Hypovitaminosis |
2.8% |
Nasopharyngitis |
2.8% |
Pleurisy |
2.8% |
Pneumonia |
2.8% |
Pollakiuria |
2.8% |
Reflux Oesophagitis |
2.8% |
|
Lung Disorder |
25.0% |
Platelet Count Decreased |
25.0% |
Hypocalcaemia |
12.5% |
Hypomagnesaemia |
12.5% |
Visual Acuity Reduced |
12.5% |
Vitreous Detachment |
12.5% |
|
Concomitant |
Product Used For Unknown Indication |
11.0% |
Prophylaxis |
9.2% |
Hypertension |
9.1% |
Gastritis |
8.1% |
Constipation |
7.3% |
Insomnia |
6.0% |
Drug Use For Unknown Indication |
5.8% |
Graft Versus Host Disease |
5.8% |
Rheumatoid Arthritis |
5.3% |
Osteoporosis |
4.6% |
Pancreatitis Chronic |
4.2% |
Nausea |
4.0% |
Stomatitis |
3.6% |
Gastrointestinal Disorder |
2.7% |
Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
Chronic Myeloid Leukaemia |
2.4% |
Crohn's Disease |
2.1% |
Dyspepsia |
2.1% |
Gastric Ulcer |
2.1% |
Hiv Infection |
2.1% |
|
White Blood Cell Count Decreased |
12.4% |
Pyrexia |
11.0% |
Vomiting |
9.0% |
Platelet Count Decreased |
8.3% |
Cellulitis |
4.8% |
Nausea |
4.8% |
Pneumonia |
4.8% |
Rash |
4.8% |
Pancytopenia |
4.1% |
Red Blood Cell Count Decreased |
4.1% |
Somnolence |
4.1% |
Hypokalaemia |
3.4% |
Pneumonia Aspiration |
3.4% |
Shock |
3.4% |
Thrombotic Microangiopathy |
3.4% |
Ascites |
2.8% |
Hepatic Function Abnormal |
2.8% |
Malaise |
2.8% |
Neuropathy Peripheral |
2.8% |
Off Label Use |
2.8% |
|
Interacting |
Drug Use For Unknown Indication |
100.0% |
|
|